查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561560

2024-2032 年按樣本類型、生物樣本庫類型、應用、最終用戶和地區分類的生物樣本庫市場報告

Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球生物銀行IMARC Group規模達到610億美元。基因組研究活動數量的增加、慢性病盛行率的增加以及對虛擬生物庫的日益關注是推動市場發展的一些關鍵因素。

生物樣本庫是指收集、儲存、註釋和重新分配體液或組織樣本以進行研究的過程，以提高對健康和疾病的了解。它是一個可靠的樣本中心，可以存取高品質樣本池和相關資料。它對於多種疾病的診斷和藥物生產至關重要。它為改進個人化醫療方法提供了基礎，其中有效的生物標記識別對於疾病診斷和預後至關重要。它充當眾多研究和不同研究的捐助者和研究人員之間的調解人。它具有高品質的控制，有助於提高各種實驗的再現性。它還提供透過生物樣本產生的資料，這對於衛生系統的數位轉型至關重要。因此，生物樣本庫在全球廣泛應用於藥物和生物標記開發、臨床治療護理以及監測藥物對最終結果影響的臨床試驗。

生物樣本庫市場趨勢：

目前，由於基因組研究活動數量的增加，對生物樣本庫的需求不斷成長，這是支持市場成長的關鍵因素之一。除此之外，全球範圍內越來越多的生物樣本庫，由於其具有提高生物醫學研究資料的再現性和意義的潛力，正在提供積極的市場前景。此外，世界各地的群眾中糖尿病、高血壓、癌症、心臟病和呼吸系統疾病等慢性病的盛行率也在上升。再加上對生物樣本庫開發能夠有效識別病原體的診斷方法的需求不斷增加，正在推動市場的成長。除此之外，再生醫學、個人化醫學和癌症基因組研究等先進療法的支出不斷增加，為產業投資者提供了利潤豐厚的成長機會。此外，臨床實驗室對生物樣本開發基因檢測方法的需求不斷增加，對市場產生了積極影響。此外，人們越來越關注虛擬生物庫，它可以最大限度地減少時間限制，產生高收入，並允許研究人員順利進行研究，這也促進了市場的成長。此外，主要參與者正在推出生物樣本庫軟體解決方案，該解決方案有助於提高知名度並提高為客戶提供的服務質量，從而加強市場成長。

本報告回答的關鍵問題

  • 2023 年全球生物樣本庫市場規模有多大？ 2024-2032年全球生物樣本庫市場的預期成長率是多少？
  • 推動全球生物樣本庫市場的關鍵因素是什麼？
  • COVID-19 對全球生物樣本庫市場有何影響？
  • 根據標本類型，全球生物樣本庫市場的細分如何？
  • 根據生物樣本庫類型，全球生物樣本庫市場的分類是怎麼樣的？
  • 基於應用的全球生物樣本庫市場的詳細情形如何？
  • 基於最終用戶的全球生物樣本庫市場的分類是怎麼樣的？
  • 全球生物樣本庫市場的關鍵區域有哪些？
  • 誰是全球生物樣本庫市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物樣本庫市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依樣本類型

  • 血液製品
    • 市場趨勢
    • 市場預測
  • 固體組織
    • 市場趨勢
    • 市場預測
  • 細胞系
    • 市場趨勢
    • 市場預測
  • 核酸
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依生物樣本庫類型

  • 基於人群的生物樣本庫
    • 市場趨勢
    • 市場預測
  • 以疾病為導向的生物樣本庫
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 療法
    • 市場趨勢
    • 市場預測
  • 研究
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 學術機構
    • 市場趨勢
    • 市場預測
  • 製藥和生物技術公司
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Brooks Automation Inc.
    • Bay Biosciences LLC
    • Boca Biolistics
    • Ctibiotech
    • Cureline Inc.
    • Firalis
    • Greiner Bio-One International GmbH
    • Hamilton Company
    • Merck KGaA
    • ProteoGenex Inc.
    • Thermo Fisher Scientific Inc.
    • VWR Corporation (Avantor Inc.)
Product Code: SR112024A4967

The global biobanking market size reached US$ 61.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The rising number of genomic research activities, increasing prevalence of chronic diseases, and rising focus on virtual biobank represent some of the key factors driving the market.

Biobanking refers to the process wherein samples of bodily fluid or tissue are collected, stored, annotated, and redistributed for research to improve the understanding of health and disease. It is a reliable hub of samples and enables access to a pool of high-quality samples and associated data. It is essential for the diagnosis and production of medicines for numerous disorders. It provides a basis for improving personalized medical approaches wherein effective biomarker identification is vital for disease diagnosis and prognosis. It serves as a mediator between donor and researcher for numerous research and different studies. It has high-quality control and assists in improving the reproducibility of various experiments. It also offers data generated through biosamples that is crucial for the digital transformation of health systems. As a result, biobanking is widely utilized in drug and biomarker development, clinical care for therapy, and clinical trials monitoring for the effects of drugs on eventual outcomes across the globe.

Biobanking Market Trends:

At present, the rising demand for biobanking due to the increasing number of genomic research activities represents one of the key factors supporting the growth of the market. Besides this, the growing number of biobanks across the globe, due to its potential to enhance the reproductivity and meaning of data generated by biomedical research, is offering a positive market outlook. Additionally, there is a rise in the prevalence of chronic diseases, such as diabetes, hypertension, cancer, heart attack, and respiratory disorders, among the masses around the world. This, coupled with the increasing demand for biobanking to develop diagnostics that can effectively identify pathogens, is propelling the growth of the market. Apart from this, the rising expenditure in advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, is offering lucrative growth opportunities to industry investors. Moreover, the increasing demand for biospecimens from clinical labs to develop assays for genetic testing is positively influencing the market. In addition, the growing focus on virtual biobank that minimizes time constraints, generates high revenue, and allows researchers to conduct the research smoothly is contributing to the growth of the market. Furthermore, key players are introducing a biobank software solution that assists in gaining visibility and improving the quality of the service provided to customers, which is strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on specimen type, biobank type, application and end user.

Specimen Type Insights:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

The report has provided a detailed breakup and analysis of the biobanking market based on the specimen type. This includes blood products, solid tissue, cell lines, nucleic acid, and others. According to the report, blood products represented the largest segment.

Biobank Type Insights:

  • Population-based Biobanks
  • Disease-oriented Biobanks

A detailed breakup and analysis of the biobanking market based on the biobank type has also been provided in the report. This includes population-based biobanks and disease-oriented biobanks. According to the report, disease-oriented biobanks accounted for the largest market share.

Application Insights:

  • Therapeutics
  • Research

A detailed breakup and analysis of the biobanking market based on the application has also been provided in the report. This includes therapeutics and research. According to the report, research accounted for the largest market share.

End-User Insights:

  • Academic Institutions
  • Pharma and Biotech Companies

A detailed breakup and analysis of the biobanking market based on the end-user has also been provided in the report. This includes academic institutions and pharma and biotech companies. According to the report, academic institutions accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe was the largest market for biobanking. Some of the factors driving the Europe biobanking market included rising advancements in the stem cell and regenerative medicine research, increasing awareness about stem cell therapies, high demand for automated alarm monitoring devices, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global biobanking market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc., VWR Corporation (Avantor Inc.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global biobanking market in 2023?
  • 2. What is the expected growth rate of the global biobanking market during 2024-2032?
  • 3. What are the key factors driving the global biobanking market?
  • 4. What has been the impact of COVID-19 on the global biobanking market?
  • 5. What is the breakup of the global biobanking market based on the specimen type?
  • 6. What is the breakup of the global biobanking market based on the biobank type?
  • 7. What is the breakup of the global biobanking market based on the application?
  • 8. What is the breakup of the global biobanking market based on the end user?
  • 9. What are the key regions in the global biobanking market?
  • 10. Who are the key players/companies in the global biobanking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biobanking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Specimen Type

  • 6.1 Blood Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Solid Tissue
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Nucleic Acid
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Biobank Type

  • 7.1 Population-based Biobanks
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disease-oriented Biobanks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Therapeutics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Academic Institutions
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharma and Biotech Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Brooks Automation Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bay Biosciences LLC
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boca Biolistics
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Ctibiotech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Cureline Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Firalis
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Greiner Bio-One International GmbH
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Hamilton Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 ProteoGenex Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 VWR Corporation (Avantor Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Biobanking Market: Major Drivers and Challenges
  • Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2023
  • Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2023
  • Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Biobanking Industry: SWOT Analysis
  • Figure 81: Global: Biobanking Industry: Value Chain Analysis
  • Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biobanking Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2024-2032
  • Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2024-2032
  • Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Biobanking Market: Competitive Structure
  • Table 8: Global: Biobanking Market: Key Players